SCHEMBL7119563

SCHEMBL7119563

CCC(=O)Oc1ccc(F)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.46
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MEN1 O00255 1/20 0.43
SLC6A2 P23975 2/20 0.42
SLC6A3 Q01959 2/20 0.42
SLC6A4 P31645 1/20 0.42
ACHE P22303 1/20 0.42
PKM P14618 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
S1PR4 O95977 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27525702 0.87 ALOX15 (0.49) ALOX15NPC1RAB9AALDH1A1KMT2A
SCHEMBL27538598 0.84 NPC1 (0.42) NPC1RAB9AALDH1A1KMT2AL3MBTL1
SCHEMBL27693027 0.83 ALOX15 (0.52) ALOX15ALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL9799896 0.83 L3MBTL1 (0.55) ALOX15NPC1RAB9AALDH1A1KMT2A
SCHEMBL1994886 0.83 ALOX15 (0.49) ALOX15KMT2AL3MBTL1MEN1ACHE
SCHEMBL1678635 0.83 L3MBTL1 (0.55) ALOX15NPC1RAB9AALDH1A1KMT2A
SCHEMBL9422499 0.81 ESR1 (0.51) ALOX15ALDH1A1KMT2AL3MBTL1ACHE
SCHEMBL27757322 0.81 ALOX15 (0.47) ALOX15KMT2AACHEPKMKDM4E
SCHEMBL18322432 0.81 ACHE (0.50) ALOX15ALDH1A1KMT2AL3MBTL1ACHE
SCHEMBL2031215 0.81 SMN1; SMN2 (0.45) NPC1RAB9AALDH1A1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106414442-A 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS 因赛特公司 2017-02-15 CN disclosed
CN-101815713-B Polycyclic compounds EISAI R&D MAN CO LTD 2013-09-11 CN disclosed
WO-2003076403-A1 1,2-DISUBSTITUDED-6-OXO-3-PHENYL-PIPERIDINE-3-CARBOXAMIDES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2003-09-18 WO disclosed
US-20030171588-A1 1,2-disubstituted-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof LION BIOSCIENCE AG (DE) 2003-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171588-A1 1,2-disubstituted-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof BRD4, BICRA, HDAC6 ALOX15 4786/4885NPC1 3847/4885RAB9A 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.